9966 — Alphamab Oncology Share News
0.000.00%
Last trade - 00:00- HK$5.54bn
- HK$4.18bn
- CNY566.24m
Brief: Alphamab Oncology Says Simcere Pharmaceutical Granted An Exclusive Marketing Right In PRC
Brief: Alphamab Oncology Announces Clinical Supply Collaboration With Pfizer On Kn026 In Combination With Ibrance(R) (Palbociclib)
Brief: Alphamab Oncology Says Unit And Pfizer Enter Clinical Trial Agreement
Brief: Alphamab Oncology Says Four Ind Applications Accepted By Nmpa Cde For Two Anti-Tumor Bisepecific Antibodies In Pipeline
Brief: Alphamab Oncology Says Unit Has Passed On-Site Inspection Of An European Union Qualified Person
Brief: Alphamab Oncology Says Unit, Tracon Pharmaceuticals And 3D Medicines (Beijing) Entered Into Agreement
Brief: Tracon Pharmaceuticals, 3D Medicines And Jiangsu Alphamab Announce Partnership To Develop Pd-L1 Single-Domain Antibody In Soft Tissue Sarcoma
Cancer drug firm Alphamab jumps on HK debut, game developer XD climbs